Moderna sees higher COVID vaccine sales later this year
Moderna Inc on Wednesday forecast higher vaccine sales for the second half of the year than in the first six months, as it expects the virus that causes COVID-19 to follow a more seasonal pattern requiring booster shots in the fall.
View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-keeps-full-year-covid-vaccine-sales-view-unchanged-2022-05-04/